Next Investors logo grey
ASX:RGS

Regeneus

ASX:RGS
- Regeneus

There is no investment memo published for this company

Regeneus and Kyocera ink lucrative deal to commercialise Progenza in $3.5 billion dollar market

Aug 11, 2020

Regeneus and Kyocera ink lucrative deal to commercialise Progenza in $3.5 billion dollar market

Regeneus surges on back of Progenza patent news

Mar 23, 2020

Regeneus surges on back of Progenza patent news

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

Mar 20, 2020

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

Regeneus inks agreement with high profile Japanese life sciences group

Mar 3, 2020

Regeneus inks agreement with high profile Japanese life sciences group

Can This ASX Junior Surge Through the Pain Barrier?

Mar 2, 2020

Can This ASX Junior Surge Through the Pain Barrier?